Inventurus Knowledge Solutions Limited IPO
Inventurus Knowledge Solutions Limited (IKS) is a leading healthcare revenue cycle management (RCM) company offering technology-driven financial and administrative solutions to healthcare providers. The company launched its ₹2,497.92 crore IPO in December 2024, with a price band of ₹1,265 - ₹1,329 per share. The IPO was oversubscribed 52.68 times and listed at a 43% premium on NSE at ₹1,900. IKS continues to expand its global presence, leveraging AI and automation to enhance healthcare financial operations.
Min Investment
₹14,619
Price Range
₹1,265.0 - 1,329.0
Issue Size
₹2,497.92 Cr
IPO Type
Mainboard
Key Metrics
Face Value
₹ 1 per share
EPS
₹ 24.31
P/E Ratio
54.66 x
RoNW
32%
ROE
37.63%.
Debt to Equity
0.68
Timeline
IPO Opens
12/12/2024
IPO Closes
16/12/2024
Allotment
17/12/2024
Refund
18/12/2024
Listing
19/12/2024
IPO Objectives
- The company will not receive any proceeds from the Offer and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.
Strengths
- Strong Financial Performance: Consistently high ROE (37.63%) and growing revenues indicate profitability and operational efficiency.
- Moderate Debt Levels: With a Debt-to-Equity ratio of 0.68, the company maintains a balanced capital structure compared to industry peers.
- Global Presence & Client Base: Serves leading healthcare providers worldwide, ensuring stable revenue and long-term contracts.
- Technology-Driven Operations: Leverages AI and automation to enhance healthcare revenue cycle management, improving efficiency.
Weaknesses
- High Debt Levels: With a Debt-to-Equity ratio of 0.68, the company has higher leverage compared to industry peers, increasing financial risk.
- Client Concentration Risk: A significant portion of revenue comes from a few large healthcare clients, making the business vulnerable to contract losses.
- Regulatory Challenges: Operating in the healthcare sector, the company must comply with strict regulations, which could impact operations and profitability.
- Operational Costs: High investments in technology and skilled workforce increase expenses, potentially affecting profit margins.
Financials
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets (₹Cr) | 2,790.52 | 3,027.52 | 988.31 | 787.52 |
| Revenue (₹Cr) | 1,294.61 | 1,857.94 | 1,060.16 | 784.47 |
| Profit After Tax (₹Cr) | 208.58 | 370.49 | 305.23 | 232.97 |
| Net Worth (₹Cr) | 1,377.11 | 1,157.86 | 828.64 | 647.07 |
| Reserves and Surplus (₹Cr) | 1,360.17 | 1,140.94 | 811.80 | 630.26 |
| Total Borrowing (₹Cr) | 828.63 | 1,193.42 |
Peer Comparison
| Company | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|---|---|---|
| Inventurus Knowledge Solutions Limited IPO | 54.66x | 32% | 1,377.11 (₹Crore) |
Subscription Details
IPO Bidding Live Updates from BSE, NSE
| Day | # of Share Offered | Number of Lots Offered | 12th Dec 2024 19:04 | 13th Dec 2024 19:04 | 16th Dec 2024 18:17 |
|---|---|---|---|---|---|
| QIB | 56,19,154 | 510832 | 1.54x | 1.89x | 80.64x |
| NII | 28,09,576 | 255416 | 0.79x | 3.13x | 23.25x |
| S-NII | 9,36,525 | 85139 | 0.94x | 3.36x | 19.77x |
| B-NII | 18,73,051 | 170277 | 0.72x | 3.02x | 24.99x |
| RII | 18,73,050 | 170277 | 1.70x | 4.26x | 14.55x |
| Total | 1,03,66,780 | 942435 | 1.36x | 2.66x | 52.68x |
IPO Bidding Live Number of Shares by Category
| Category | Number of Shares offered | Number of Shares Bid | Bid Amount(Rs Cr) | ||
|---|---|---|---|---|---|
| QIB | 56,19,154 | 45,31,55,846 | 60,224.41 | ||
| NII | 28,09,576 | 6,53,31,398 | 8,682.54 | ||
| Small NII | 9,36,525 | 1,85,16,520 | 2,460.85 | ||
| Big NII | 18,73,051 | 4,68,14,878 | 6,221.70 | ||
| RII | 18,73,050 | 2,72,56,603 | 3,622.40 | ||
| Total | 1,03,66,780 | 54,60,81,734 | 72,574.26 |
Company Details
- Building No. 5 & 6, Unit No. 801, 8th Floor, Mindspace SEZ, Thane Belapur Road, Airoli, Navi Mumbai, Thane, 400708
+91 22 3964 3205
- company.secretary@ikshealth.com
- N/A
Registrar Details
- C-101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai - 400083, Maharashtra, India
+91-22-4918 6270
- ikshealth.ipo@linkintime.co.in
- https://linkintime.co.in/Initial_Offer/public-issues.html
